|
Follow the links below to find information on chemotherapy for breast cancer.
Reviewed August 2008
Printer friendly page
Related HealthInsite Topics
| Results 1 to 11 displayed. |
| Title: |
Media release. New PBS listings for May 2008
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
Women with advanced breast cancer, people with hypertension and people with osteoporosis will benefit from new listings on the Pharmaceutical Benefits Scheme.
|
| Date: |
May 2008
|
| Title: |
Media release. New breast cancer drug to be subsidised
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
From May 1, women suffering from a particularly aggressive form of breast cancer will have access to a new drug, lapatinib (Tykerb), on the PBS.
|
| Date: |
Apr 2008
|
| Title: |
PBAC: taxanes
|
| Publisher: |
Australian Prescriber
|
| Description: |
The listing of trastuzumab on the Pharmaceutical Benefits Scheme (PBS) in October 2006 was heralded with much fanfare. Along with this listing, changes to the prescribing requirements for taxanes also occurred.
|
| Date: |
Feb 2007
|
| Title: |
Side effects of chemotherapy treatment for breast cancer
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Research has shown that more than 50% of cancer patients receiving chemotherapy have some side effects ranging from nausea, tiredness and hair loss to concern about family members depression and dread of treatment.
|
| Date: |
Nov 2006
|
| Title: |
Chemotherapy clinical trials
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Clinical trials are studies involving patients conducted in order to help find better ways to prevent, diagnose or treat diseases.
|
| Date: |
Nov 2006
|
| Title: |
Listing of Herceptin on the PBS
|
| Publisher: |
Australian Government Department of Health and Ageing
|
| Description: |
The Government has accepted a recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC) to list the drug trastuzumab (Herceptin?) on the Pharmaceutical Benefits Scheme (PBS).
|
| Date: |
Oct 2006
|
| Title: |
Breast cancer
|
| Publisher: |
The Jean Hailes Foundation for Women's Health
|
| Description: |
Women who develop breast cancer may be at risk of osteoporosis.
|
| Date: |
Feb 2006
|
| Title: |
Cancer antibodies (Comment for consumers)
|
| Publisher: |
Australian Prescriber
|
| Description: |
To reduce side effects, new treatments are needed which will kill the cancer cells but not damage normal cells. One approach is to make antibodies against the cancer cells.
|
| Date: |
Dec 2003
|
| Title: |
Antineoplastic antibodies - clinical applications
|
| Publisher: |
Australian Prescriber
|
| Description: |
Trastuzumab and rituximab are genetically engineered antibodies which are now available for the treatment of metastatic breast cancer and non-Hodgkin's lymphoma respectively.
|
| Date: |
Dec 2003
|
| Title: |
Chemotherapy treatment for breast cancer
|
| Publisher: |
National Breast Cancer Centre (NBCC)
|
| Description: |
Chemotherapy is the use of drugs to kill cancer cells. Cells grow by dividing. Chemotherapy works by damaging cancer cells that are dividing. It travels around the body in the blood stream attacking cells.
|
| Date: |
Oct 2003
|
| Results 1 to 11 displayed. |
|
